1302P MET×MET bispecific antibody davutamig (REGN5093) for MET-altered advanced non-small cell lung cancer (aNSCLC): Update from a first-in-human (FIH) study

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 35; pp. S828 - S829
Main Authors	Cho, B.C., Ahn, M-J., Kim, T.M., Kim, S-W., Han, J-Y., Kim, C., Shim, B., Ricordel, C., Drilon, A.E., Pujol, J-L., Gray, J.E., Villaruz, L., Blumenschein, G., Perez, J., Modi, D.A., Kaul, M., Patel, S., Hao, Y., Kim, E., Magnan, H.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.09.2024
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2024.08.1359